|
ANKRD44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.082800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.160200E-01 |
| Normal-vs-Stage2 |
3.316600E-01 |
| Normal-vs-Stage3 |
7.063800E-01 |
| Normal-vs-Stage4 |
2.619800E-01 |
| Stage1-vs-Stage2 |
1.976790E-01 |
| Stage1-vs-Stage3 |
6.180600E-01 |
| Stage1-vs-Stage4 |
4.399600E-01 |
| Stage2-vs-Stage3 |
7.344200E-01 |
| Stage2-vs-Stage4 |
1.494450E-01 |
| Stage3-vs-Stage4 |
3.993400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.480800E-01 |
| Normal-vs-AfricanAmerican |
3.888400E-01 |
| Normal-vs-Asian |
4.862600E-01 |
| Caucasian-vs-AfricanAmerican |
1.643610E-01 |
| Caucasian-vs-Asian |
6.730600E-01 |
| AfricanAmerican-vs-Asian |
8.982000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.168000E-01 |
| Normal-vs-Female |
4.311800E-02 |
| Male-vs-Female |
1.028270E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.732200E-01 |
| Normal-vs-Extreme_Weight |
3.109000E-01 |
| Normal-vs-Obese |
3.521000E-01 |
| Normal-vs-Extreme_Obese |
4.982000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.944400E-01 |
| Normal_Weight-vs-Obese |
9.737200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.140170E-01 |
| Extreme_Weight-vs-Obese |
9.161700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.424600E-01 |
| Obese-vs-Extreme_Obese |
1.054220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.307800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.332600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.525400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.407200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.193600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.477200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.560800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.158800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.451200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.982400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.694000E-01 |
| Normal-VS-Type2 PRCC |
4.382200E-01 |
| Normal-VS-KIRP CIMP |
7.218800E-01 |
| Normal-VS-Unclassified PRCC |
1.656790E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.854400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.126600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.230370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.512600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.768200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.415950E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.466000E-01 |
| Normal-vs-N1 |
5.317200E-01 |
| Normal-vs-N2 |
6.631800E-01 |
| N0-vs-N1 |
5.645400E-01 |
| N0-vs-N2 |
6.371800E-01 |
| N1-vs-N2 |
9.967800E-01 |
|
|
